Cargando…
Parkinson’s Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats
Parkinson’s disease (PD) is known to be associated with altered gastrointestinal function and microbiota composition. To date, the effect of PD medication on the gastrointestinal function and microbiota, at the site of drug absorption, the small intestine, has not been studied, although it may repre...
Autores principales: | van Kessel, Sebastiaan P., Bullock, Amber, van Dijk, Gertjan, El Aidy, Sahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788331/ https://www.ncbi.nlm.nih.gov/pubmed/35076270 http://dx.doi.org/10.1128/msystems.01191-21 |
Ejemplares similares
-
Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019) -
Gut bacteria-derived 5-hydroxyindole is a potent stimulant of intestinal motility via its action on L-type calcium channels
por: Waclawiková, Barbora, et al.
Publicado: (2021) -
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019) -
The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals
por: Vinke, Petra C., et al.
Publicado: (2017) -
Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019)